Information Provided By:
Fly News Breaks for July 16, 2019
Jul 16, 2019 | 07:08 EDT
B. Riley FBR analyst Andrew D'Silva downgraded Kindred Biosciences to Neutral from Buy and lowered his price target for the shares to $8.50 from $18.
News For KIN From the Last 2 Days
There are no results for your query KIN